Align Technology, Inc.

ALGN • Medical - Devices

$158.63

▼ -1.22 (-0.76%)

Current price

EarningsLatest report: Jun 30, 2026

BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.

Market Cap

$11.37B

Growth

27.6%

Cash Flow

5/5

Trend

Stable

Evidence

Stable or improving margins · 10.2%Positive free cash flow · 6.77Consistent free cash flow · 5/5Manageable debt level · 0.03Healthy liquidity · 1.36

Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:30 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$158.64

Change-0.76%

Shares Out71.63M

Market Cap$11.37B

Enterprise Value$10.35B

52W Range122.00 - 200.44

Beta1.67

P/E27.48

P/S2.75

P/B2.69

P/FCF14.16

EV/Sales2.50

Price$158.64

Change-0.76%

Shares Out71.63M

Market Cap$11.37B

Enterprise Value$10.35B

52W Range122.00 - 200.44

Beta1.67

P/E27.48

P/S2.75

P/B2.69

P/FCF14.16

EV/Sales2.50

EV/EBITDA14.88

EV/FCF12.90

Earnings Yield3.64%

FCF Yield7.06%

Dividend Yield0.00%

Gross Margin68.33%

Oper. Margin15.27%

Profit Margin10.17%

Debt/Eq0.03

Current Ratio1.36

Quick Ratio1.24

Revenue 5Y27.65%

Target$205.25

Target Upside29.39%

Target Median$199.00

Target Range188.00 - 235.00

Volume629.74K

Avg Volume1.02M

EPS Surprise0.32

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

60/100

Financial Strength

Debt, cash, stability

67/100

Growth Potential

Revenue and expansion

33/100

Price Attractiveness

Cheap or expensive today

68/100

Why this score▼

Stable or improving margins · 10.2%Positive free cash flow · 6.77Consistent free cash flow · 5/5Manageable debt level · 0.03Healthy liquidity · 1.36Negative growth trend

Analyst view

Analyst sentiment and price target

ALGN

Analyst sentiment

Based on 33 analyst votes · 2026-09-04

83/100

Bullish

Hold

Bearish

Price Target

2026-08-07

Low

$188.00

Mean

$203.50

Median

$200.00

High

$235.00

Company Overview

IPO: 1/30/2001

Industry: Medical - Devices

P/B i: 2.69

Debt / Equity i: 0.03

Operating Margin: 15.27%

Net Margin: 10.17%

ROE i: -

ROIC: -

Financial Health

Score13 / 20

Debt / Equity: 0.03

Current Ratio: 1.36

Quick Ratio: 1.24

Status: Good

Insider Transactions

Recent executive and insider activity

MORROW GEORGE J

Transaction: 05/20/2026

SELL

Change

-1,745

Price

Not reported

Filing

05/22/2026

Type

SELL

MORROW GEORGE J

Transaction: 05/20/2026

BUY

Change

+1,745

Price

Not reported

Filing

05/22/2026

Type

BUY

Conroy Kevin T

Transaction: 05/20/2026

SELL

Change

-1,745

Price

Not reported

Filing

05/22/2026

Type

SELL

Insider	Type	Change	Price	Transaction	Filing
MORROW GEORGE J	SELL	-1,745	Not reported	05/20/2026	05/22/2026
MORROW GEORGE J	BUY	+1,745	Not reported	05/20/2026	05/22/2026
Conroy Kevin T	SELL	-1,745	Not reported	05/20/2026	05/22/2026
Conroy Kevin T	BUY	+1,745	Not reported	05/20/2026	05/22/2026
LACOB JOSEPH	SELL	-1,745	Not reported	05/20/2026	05/22/2026
LACOB JOSEPH	BUY	+1,745	Not reported	05/20/2026	05/22/2026
Dallas Kevin J	SELL	-1,745	Not reported	05/20/2026	05/22/2026
Dallas Kevin J	BUY	+1,745	Not reported	05/20/2026	05/22/2026
LARKIN C RAYMOND JR	SELL	-2,326	Not reported	05/20/2026	05/22/2026
LARKIN C RAYMOND JR	BUY	+2,326	Not reported	05/20/2026	05/22/2026
Myong Anne	SELL	-1,745	Not reported	05/20/2026	05/22/2026
Myong Anne	BUY	+1,745	Not reported	05/20/2026	05/22/2026
Poul Mojdeh	SELL	-1,745	Not reported	05/20/2026	05/22/2026
Poul Mojdeh	BUY	+1,745	Not reported	05/20/2026	05/22/2026
Saia Andrea Lynn	SELL	-1,745	Not reported	05/20/2026	05/22/2026
Saia Andrea Lynn	BUY	+1,745	Not reported	05/20/2026	05/22/2026
SIEGEL SUSAN E	SELL	-1,745	Not reported	05/20/2026	05/22/2026
SIEGEL SUSAN E	BUY	+1,745	Not reported	05/20/2026	05/22/2026
Vitalone Britt J.	BUY	+1,443	Not reported	05/20/2026	05/22/2026
Vitalone Britt J.	SELL	-1,443	Not reported	05/20/2026	05/22/2026

About the Company

Align Technology, Inc.

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

Source - link

Peers

BIO BMRN ENSG EXEL GMED HIMS PEN QGEN RVTY

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

Quentin Blackford to Join Align Technology Board of Directors

TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Quentin Blackford, President and Chief Executive Officer of iRhythm Technologies, as a director effective immediat.

Business Wire

26,510 Shares in Align Technology, Inc. $ALGN Acquired by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board bought a new position in Align Technology, Inc. (NASDAQ: ALGN) in the quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 26,510 shares of the medical equipment provider's stock, valued at approximately $4,471,000. Other institutional

Defense World

Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research

Align Technology Inc (ALGN) Stock Down 5.6% -- Now Undervalued? GF Score: 89/100

On August 17, 2026, Align Technology Inc (ALGN) shares fell 5.6%, bringing the current price to $171.16. The stock has experienced a 52-week range of $122.00 to

GuruFocus

How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook

Align's $37.5M U.K. VAT liability, new 20% VAT charges and pending appeal add fresh earnings uncertainty amid currency and mix pressures.

Zacks Investment Research

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-04-29	2.26	2.58	0.32
2026-02-04	2.99	3.29	0.3
2025-10-29	2.4	2.61	0.21
2025-07-30	2.57	2.49	-0.08
2025-04-30	1.99	2.13	0.14
2025-02-05	2.43	2.44	0.01
2024-10-23	2.31	2.35	0.04
2024-07-24	2.34	2.41	0.07
2024-04-24	1.97	2.14	0.17
2024-01-31	2.18	2.42	0.24
2023-10-25	2.26	2.14	-0.12
2023-07-26	2.02	2.22	0.2